These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16265260)

  • 1. Technology insight: targeting of biological molecules for evaluation of high-risk atherosclerotic plaques with magnetic resonance imaging.
    Lipinski MJ; Fuster V; Fisher EA; Fayad ZA
    Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):48-55. PubMed ID: 16265260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance molecular imaging contrast agents and their application in atherosclerosis.
    Mulder WJ; Strijkers GJ; Vucic E; Cormode DP; Nicolay K; Fayad ZA
    Top Magn Reson Imaging; 2007 Oct; 18(5):409-17. PubMed ID: 18025995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes.
    Briley-Saebo KC; Mulder WJ; Mani V; Hyafil F; Amirbekian V; Aguinaldo JG; Fisher EA; Fayad ZA
    J Magn Reson Imaging; 2007 Sep; 26(3):460-79. PubMed ID: 17729343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plaque imaging and characterization using magnetic resonance imaging: towards molecular assessment.
    Sirol M; Fuster V; Fayad ZA
    Curr Mol Med; 2006 Aug; 6(5):541-8. PubMed ID: 16918374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accurate magnetic resonance imaging of atherosclerotic plaques: change future strategies for the diagnosis and therapy of atherosclerotic disease.
    Liu XS; Xu JR
    Med Hypotheses; 2007; 68(3):656-60. PubMed ID: 17014968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach.
    Lancelot E; Amirbekian V; Brigger I; Raynaud JS; Ballet S; David C; Rousseaux O; Le Greneur S; Port M; Lijnen HR; Bruneval P; Michel JB; Ouimet T; Roques B; Amirbekian S; Hyafil F; Vucic E; Aguinaldo JG; Corot C; Fayad ZA
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):425-32. PubMed ID: 18258820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and molecular detection of atherothrombosis by magnetic resonance--potential tools for individual risk assessment and diagnostics.
    Ala-Korpela M; Sipola P; Kaski K
    Ann Med; 2006; 38(5):322-36. PubMed ID: 16938802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of magnetic resonance and intravascular magnetic resonance in the detection of vulnerable plaques.
    Wilensky RL; Song HK; Ferrari VA
    J Am Coll Cardiol; 2006 Apr; 47(8 Suppl):C48-56. PubMed ID: 16631510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ApoA-I mimetic peptide high-density-lipoprotein-based MRI contrast agent for atherosclerotic plaque composition detection.
    Cormode DP; Briley-Saebo KC; Mulder WJ; Aguinaldo JG; Barazza A; Ma Y; Fisher EA; Fayad ZA
    Small; 2008 Sep; 4(9):1437-44. PubMed ID: 18712752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The progress of nuclear medicine and magnetic resonance molecular imaging of atherosclerotic vulnerable plaques].
    Zhao ZM; Qin SC
    Sheng Li Ke Xue Jin Zhan; 2011 Apr; 42(2):86-90. PubMed ID: 21770253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted contrast agent helps to monitor advanced plaque during progression: a magnetic resonance imaging study in rabbits.
    Zheng J; Ochoa E; Misselwitz B; Yang D; El Naqa I; Woodard PK; Abendschein D
    Invest Radiol; 2008 Jan; 43(1):49-55. PubMed ID: 18097277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive imaging of atherosclerotic vessels by MRI for clinical assessment of the effectiveness of therapy.
    Corti R
    Pharmacol Ther; 2006 Apr; 110(1):57-70. PubMed ID: 16445985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular imaging by cardiovascular MR.
    Cyrus T; Lanza GM; Wickline SA
    J Cardiovasc Magn Reson; 2007; 9(6):827-43. PubMed ID: 18066742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution magnetic resonance imaging using gadolinium-based contrast agent for atherosclerotic carotid plaque.
    Kawahara I; Morikawa M; Honda M; Kitagawa N; Tsutsumi K; Nagata I; Hayashi T; Koji T
    Surg Neurol; 2007 Jul; 68(1):60-5; discussion 65-6. PubMed ID: 17586225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genesis and dynamics of atherosclerotic lesions: implications for early detection.
    Badimon JJ; Ibanez B; Cimmino G
    Cerebrovasc Dis; 2009; 27 Suppl 1():38-47. PubMed ID: 19342832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying the vulnerable patient with rupture-prone plaque.
    Weintraub HS
    Am J Cardiol; 2008 Jun; 101(12A):3F-10F. PubMed ID: 18549869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadofluorine-enhanced magnetic resonance imaging of carotid atherosclerosis in Yucatan miniswine.
    Koktzoglou I; Harris KR; Tang R; Kane BJ; Misselwitz B; Weinmann HJ; Lu B; Nagaraj A; Roth SI; Carroll TJ; McPherson DD; Li D
    Invest Radiol; 2006 Mar; 41(3):299-304. PubMed ID: 16481913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular, cellular and functional imaging of atherothrombosis.
    Choudhury RP; Fuster V; Fayad ZA
    Nat Rev Drug Discov; 2004 Nov; 3(11):913-25. PubMed ID: 15520814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of inflammation in atherosclerosis.
    Spagnoli LG; Bonanno E; Sangiorgi G; Mauriello A
    J Nucl Med; 2007 Nov; 48(11):1800-15. PubMed ID: 17942804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular imaging of vulnerable plaque by cardiac magnetic resonance imaging.
    Burgstahler C; Hombach V; Rasche V
    Semin Thromb Hemost; 2007 Mar; 33(2):165-72. PubMed ID: 17340465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.